gip and glp 1 receptor agonist New Weight-Loss Drugs Are Poised to Upend Preventive Cardiology Care in Patients With Obesity Overweight Science Behind GLP 1 GIP

Researchers have also noted that 70% of diabetes patients discontinue GLP-1 receptor agonist treatment within two years, limiting the long-term efficacy of these drugs

Introduction For years, GLP-1 drugs were known mainly for managing diabetes and helping with weight loss

It mainly targets postprandial glucose

Research on healthy and diabetic individuals indicated that Exenatide alone improved control of HbA1c, fasting and postprandial blood glucose levels, weight loss, cell activity, and blood pressure [226]

Oral Semaglutide: first-in-class Oral GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus

Ornelas C, Caiado J, Lopes A, Pereira Dos Santos MC, Pereira BM